Abpro Holdings ABPO
OTC ABPO
$0.40 +0.04 (+12.59%)
As of: Oct 21, 2026 · 11:22 AM EDT

Abpro Holdings (ABPO) EBITDA (2024 - 2026)

Updated

Abpro Holdings (ABPO) reported EBITDA of -$1.17 million for Q2 2026, compared with -$2.26 million a year earlier.

Analysis

Abpro Holdings (ABPO) EBITDA (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Abpro Holdings' EBITDA came in at -$5.33 million; for FY2025, it was -$8.43 million.

  • By year, EBITDA came in at -$9.85 million in FY2024 and -$11.47 million in FY2023.
  • Five-year quarterly EBITDA spans a low of -$2.95 million in Q1 2025 and a high of -$930,000 in Q1 2026.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$930,000 (Q1 2026), -$1.89 million (Q4 2025) and -$1.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,136.82 Bn 1,105.41 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 617.41 Bn 535.94 Bn 17.26 Bn 9.10 Bn
3 AbbVie 501.29 Bn 474.40 Bn 12.70 Bn 8.33 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 297.07 Bn 261.06 Bn 11.24 Bn -
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn 5.09 Bn
7 Amgen 236.34 Bn 191.74 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 191.00 Bn 165.20 Bn 6.22 Bn -9.70 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 5.89 Bn
10 Abpro Holdings 2.36 Mn -7.68 Mn - -1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.17 Mn
Mar 31, 2026 -930,000.00
Dec 31, 2025 -1.89 Mn
Sep 30, 2025 -1.31 Mn
Jun 30, 2025 -2.20 Mn
Mar 31, 2025 -2.87 Mn
Dec 31, 2024 -2.76 Mn
Sep 30, 2024 -1.92 Mn
Jun 30, 2024 -2.33 Mn
Mar 31, 2024 -2.83 Mn
API Access

Abpro Holdings EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ABPO&period=max&api_key=YOUR_API_KEY